NCT05711810

Medicine-induced Cardiac Hemodialysis on COVID-19

Cardiac Transfer of SARS-CoV-2 Spike Protein Circulation Techniques - Medicine Induced Hemodialysis on "Vaccinated" Immune Attacks

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 1 (actual)
• Sponsor: Yang I. Pachankis · Individual
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The clinical trial studies the human pathogen of SARS-CoV-2, with a specificity in the circulating Spike 2 protein in the human system. The clinical trial hypothesizes that SARS-CoV-2 human pathogen arises from immune attacks, underlying the severe physiological symptoms that can be lethal. It further hypothesizes that the vaccines do not deal with the Spike 2 protein that causes the immune attacks.

Conditions

• Severe Acute Respiratory Syndrome-related Coronavirus
• Renal Dialysis
• Vaccines
• Myocarditis Allergic
• Infection Viral

Interventions

Type	Name	Description
DRUG	Nifedipine 30 MG	Due to initial availability of drugs and the intensities of the patient's symptoms, Nifedipine was used for initial intervention in preventing acute myocarditis from happening.
DIAGNOSTIC_TEST	Kangzhu BPCB0A-3A	The diagnostic test has been used to confirm objective parameters to guide the intervention drug dosages and accessing the risks in sudden death and long term adverse effects.
BEHAVIORAL	Low Mobility	The behavioral intervention aimed at reducing the risks of sudden and strong blood flows in the patient's system.
DRUG	Enalapril Maleate 10Mg Tab	The intervention aims to reduce the vein flows in Diastolic Blood Pressure, and the risks in blood clot formation and internal vein scratch bleeding.
DRUG	Lansoprazole 30Mg Ec Cap	The intervention aims to server the allergy-inducing proteins to induce renal hemodialysis.
DRUG	Metoprolol Succinate	Metoprolol Succinate is used to control the cardiac artery flow amounts and stabilize the patient's heart rate.
DIETARY_SUPPLEMENT	Coenzyme Q10	200 mg per day is used for supplement with the cardiac interventions.
DIETARY_SUPPLEMENT	d-alpha tocopherol acetate	The 268 mg twice per day dietary healthcare is the patient's usual daily use.
DIETARY_SUPPLEMENT	Omega-3	The 900 mg twice per day dietary healthcare is the patient's usual daily use.
DRUG	Duloxetine Hydrochloride 20 MG Oral Capsule, Delayed Release	Duloxetine hydrochloride is used for the patient's neurodiverse conditions.
DRUG	Superoxide Dismutase	Superoxide Dismutase is used to substitute the missing of antiviral drugs.

Timeline

• Start date: 2023-01-02
• Primary completion: 2023-01-10
• Completion: 2023-01-12
• First posted: 2023-02-03
• Last updated: 2023-02-03

Locations

1 site across 1 country: China

Regulatory

• FDA-regulated drug study